OneFund LLC’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.4K Sell
134
-14
-9% -$2.6K 0.02% 480
2025
Q4
$29.5K Buy
148
+4
+3% +$726 0.02% 456
2025
Q3
$22.5K Buy
144
+9
+7% +$1.43K 0.01% 480
2025
Q2
$20K Buy
+135
New +$18K 0.01% 483

Other funds holding CRL

OneFund LLC's CRL Position: Q1 2026 in Review

OneFund LLC reduced its Charles River Laboratories (CRL) stake by 9.5% in Q1 2026, selling an estimated $2.6K and leaving 134 shares worth $23.4K. The position accounts for 0.02% of the portfolio, ranked #480.

OneFund LLC first reported a position in CRL in Q2 2025 and has held it in 4 quarters since. The position peaked at $29.5K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • OneFund LLC held 134 shares of Charles River Laboratories worth $23.4K as of Q1 2026.
  • OneFund LLC sold 14 Charles River Laboratories shares in Q1 2026, an estimated $2.6K.
  • Charles River Laboratories made up 0.02% of OneFund LLC's portfolio in Q1 2026, its #480 holding.
  • OneFund LLC first reported a position in Charles River Laboratories in Q2 2025 and has held it in 4 quarters since.
  • OneFund LLC's Charles River Laboratories position peaked at $29.5K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.